Канал: Cancer Research & Treatment Fund

Welcome CR&T's 13th International Patient Symposium on MPNs

Welcome CR&T's 13th International Patient Symposium on MPNs

Naveen Pemmaraju, MD Drugs Novel Agents for MPNs in 2024

Naveen Pemmaraju, MD Drugs Novel Agents for MPNs in 2024

Stephanie Feldman, MD Cardiovascular Health in MPN Patients

Stephanie Feldman, MD Cardiovascular Health in MPN Patients

Hans Hasselbalch, MD Inflammation in the MPNs

Hans Hasselbalch, MD Inflammation in the MPNs

Ruben Mesa, MD Symptom Relief, Diet, and Exercise in MPN Patients

Ruben Mesa, MD Symptom Relief, Diet, and Exercise in MPN Patients

Ghaith Abu Zeinah, MD MPN Progression Is it predictable

Ghaith Abu Zeinah, MD MPN Progression Is it predictable

Raajit Rampal, MD,PhD Accelerated and Blast Phase MPNs

Raajit Rampal, MD,PhD Accelerated and Blast Phase MPNs

Moderated Q&A CR&T's 13th International Patient Symposium on MPNs

Moderated Q&A CR&T's 13th International Patient Symposium on MPNs

Linda Resar, MD Origins and Genetics of MPNs

Linda Resar, MD Origins and Genetics of MPNs

Q & A Session at Cancer Research & Treatment Fund's 12th International Patient Symposium on MPNs.

Q & A Session at Cancer Research & Treatment Fund's 12th International Patient Symposium on MPNs.

Richard T. Silver, MD - Managing Polycythemia Vera in 2023

Richard T. Silver, MD - Managing Polycythemia Vera in 2023

Naveen Pemmaraju, MD - Promising new drugs for MPN therapy

Naveen Pemmaraju, MD - Promising new drugs for MPN therapy

Hans Hasselbalch, MD, PhD - The Microbiomes in the MPNs

Hans Hasselbalch, MD, PhD - The Microbiomes in the MPNs

Ronald Hoffman, MD - Drivers of Progression of MPNs

Ronald Hoffman, MD - Drivers of Progression of MPNs

Roni Tamari - Demystifying bone marrow transplant for MPNs

Roni Tamari - Demystifying bone marrow transplant for MPNs

Joseph Scandura, MD PhD - Managing Essential Thrombocythemia in 2023

Joseph Scandura, MD PhD - Managing Essential Thrombocythemia in 2023

Jerry Spivak, MD - Managing Myelofibrosis in 2023

Jerry Spivak, MD - Managing Myelofibrosis in 2023

Angela Fleischman, MD, PhD - Inflammation in MPNs

Angela Fleischman, MD, PhD - Inflammation in MPNs

Richard T Silver, MD Accepts the Lifetime Achievement Award from MPN Asia

Richard T Silver, MD Accepts the Lifetime Achievement Award from MPN Asia

Ruth Fein Revell: A Patient's MPN Journey

Ruth Fein Revell: A Patient's MPN Journey

CR&T 2021 Research Update

CR&T 2021 Research Update

MPNs and Mental Health - A CR&T Webcast

MPNs and Mental Health - A CR&T Webcast

CR&T Virtual MPN Symposium 2020 - Presentations, Part 1

CR&T Virtual MPN Symposium 2020 - Presentations, Part 1

CR&T Virtual Symposium 2020 - General Q&A Session

CR&T Virtual Symposium 2020 - General Q&A Session

CR&T Virtual Symposium 2020 - Presentations, Part 2

CR&T Virtual Symposium 2020 - Presentations, Part 2

CR&T Research Update

CR&T Research Update

Diet, Exercise, and Mindfulness - Robyn Scherber, MD, MPH

Diet, Exercise, and Mindfulness - Robyn Scherber, MD, MPH

New MPN Treatments and Drugs - Srdan Verstovsek, MD, PhD

New MPN Treatments and Drugs - Srdan Verstovsek, MD, PhD

Current Management of Myelofibrosis - Ronald Hoffman, MD

Current Management of Myelofibrosis - Ronald Hoffman, MD

MPN Research Presented at the 2018 American Society of Hematology Annual Meeting - A.I. Schafer, MD

MPN Research Presented at the 2018 American Society of Hematology Annual Meeting - A.I. Schafer, MD

Essential Thrombocythemia: A Case Study - Jerry L. Spivak, MD

Essential Thrombocythemia: A Case Study - Jerry L. Spivak, MD

Current State of Stem Cell Transplants in MPN Therapy - Koen van Besien, MD

Current State of Stem Cell Transplants in MPN Therapy - Koen van Besien, MD

Polycythemia Vera and Myelofibrosis Patients Should Be Treated Early with Interferon - RT Silver, MD

Polycythemia Vera and Myelofibrosis Patients Should Be Treated Early with Interferon - RT Silver, MD

Immunotherapy - Hans Hasselbalch, MD

Immunotherapy - Hans Hasselbalch, MD

CR&T at 50: Building a World Without Cancer

CR&T at 50: Building a World Without Cancer

What Should You Expect from Your MPN Treatment? Ruben A. Mesa, MD, FACP

What Should You Expect from Your MPN Treatment? Ruben A. Mesa, MD, FACP

Summary of Drugs in Current and Future Clinical Trials - Jason R. Gotlib, MD, MS

Summary of Drugs in Current and Future Clinical Trials - Jason R. Gotlib, MD, MS

Current Developments in Stem Cell Transplantation in the MPNs - Koen van Besien, MD

Current Developments in Stem Cell Transplantation in the MPNs - Koen van Besien, MD

Current Management of Myelofibrosis - Ronald Hoffman, MD

Current Management of Myelofibrosis - Ronald Hoffman, MD

Current Management of Polycythemia Vera - Richard T. Silver, MD

Current Management of Polycythemia Vera - Richard T. Silver, MD

Current Management of Essential Thrombocythemia - Carlos Besses, MD

Current Management of Essential Thrombocythemia - Carlos Besses, MD

Biomarkers and Molecular Abnormalities: What Do Patients Need to Know? Alison Moliterno, MD

Biomarkers and Molecular Abnormalities: What Do Patients Need to Know? Alison Moliterno, MD

Natural History and Heredity - Jerry L. Spivak, MD

Natural History and Heredity - Jerry L. Spivak, MD

What Can I Expect from My MPN Treatment?

What Can I Expect from My MPN Treatment?

What is the Clinical Trial Process?

What is the Clinical Trial Process?

Laboratory Approaches to Studying MPNs

Laboratory Approaches to Studying MPNs

Genetics of MPNs From Initiation to Progression

Genetics of MPNs From Initiation to Progression

Essential Thrombocythemia: Pathogenesis and Management

Essential Thrombocythemia: Pathogenesis and Management

Current Developments in Polycythemia Vera Treatment: Is It Curable?

Current Developments in Polycythemia Vera Treatment: Is It Curable?

Current Developments in Myelofibrosis Treatment

Current Developments in Myelofibrosis Treatment

Common Complications of the MPNs

Common Complications of the MPNs

Update on JAK2 Inhibitors by Srdan Verstovsek, MD

Update on JAK2 Inhibitors by Srdan Verstovsek, MD

Update on JAK2 Inhibitors by Srdan Verstovsek, MD

Update on JAK2 Inhibitors by Srdan Verstovsek, MD

Should I take Aspirin, Plavix or Coumadin? by Babette Weksler, MD

Should I take Aspirin, Plavix or Coumadin? by Babette Weksler, MD

Update on JAK2 Inhibitors by Srdan Verstovsek, MD

Update on JAK2 Inhibitors by Srdan Verstovsek, MD

What can we expect from my MPN Treatment by Ruben Mesa , MD

What can we expect from my MPN Treatment by Ruben Mesa , MD

Can we prevent progression of the MPNs with Interferon? by Richard T. Silver, MD

Can we prevent progression of the MPNs with Interferon? by Richard T. Silver, MD

What is the Value of Epigenetic Therapy in MPN Treatment? by Ronald Hoffman MD

What is the Value of Epigenetic Therapy in MPN Treatment? by Ronald Hoffman MD

Can Genetic Analysis Predict MPN Progression? by Jerry Spivak MD

Can Genetic Analysis Predict MPN Progression? by Jerry Spivak MD

New Concepts in Basic Biology of MPNs by John Crispino, PhD

New Concepts in Basic Biology of MPNs by John Crispino, PhD